Polycystic Ovary Syndrome (PCOS) Market Size, Share, Analysis, Industry Report and Forecast 2021-2027
The global polycystic ovary syndrome (PCOS) market is anticipated to grow at a modest CAGR of around 4.0% during the forecast period (2021-2027). PCOS is an endocrine disorder found in women of childbearing age (ages 15 to 44) which affects their hormone levels. Women with PCOS produce higher-than-normal amounts of male hormones. This hormone imbalance causes their body to skip menstrual periods and makes it harder for them to get pregnant. In PCOS women’s ovaries, the reproductive organs that produce estrogen and progesterone are affected majorly. Diuretics, Insulin Sensitizing Agents, Antiandrogens, and Oral Contraceptive Pills are some of the major drugs used in the diagnosis of PCOD disorder.
To Request a Sample of our Report on Polycystic Ovary
Syndrome (PCOS) Market: https://www.omrglobal.com/request-sample/polycystic-ovary-syndrome-pcos-market
The changing lifestyles, rising obesity in women, and increasing cases
of hormonal imbalances in women are the factors that contributed to the rise in
the incidence of PCOS. According to the Centres for Disease Control and
Prevention, approximately 5 million women of reproductive age suffer from the
polycystic ovarian syndrome. Additionally, according to the International
Journal of Reproduction, Contraception, Obstetrics, and Gynecology, a study was
conducted on 170 women of reproductive age, in which 70 women were affected
with PCOS which was 41%, in which 16% were married women and 24% in unmarried
women with PCOS. Obesity in women is another major factor that increases the
chances of PCOS. Thus, the high prevalence is accelerating market growth.
However, factors such as side effects coupled with PCOS drugs such as weight gain, unwanted hair growth, increase insulin resistance, cardiovascular risks, and thromboembolic events are hindering the growth of the market. Further, the advancements in PCOS is also accelerating the market growth, For instance, in February 2020, Ava, a digital healthcare company focused on women's reproductive health, announced that it had received clearance approval from FDA for its Ava Fertility Tracker, a wearable fertility tracking sensor bracelet and accompanying app. The device aid women in ovulation prediction and facilitation of conception.
Market
Coverage
·
The
market number available for – 2020-2027
·
Base
year- 2020
·
Forecast
period- 2021-2027
Segment
Covered-
·
By Drug
Type
·
By
Diagnosis Type
·
By
Treatment Type
·
By
Distribution Channel
Regions
Covered-
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
·
Competitive
Landscape- Abbott Laboratories, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb
Co., Ferring Pharmaceuticals, Merck & Co., Inc.., Novartis AG, Teva
Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Polycystic Ovary Syndrome (PCOS) Market is Available
at: https://www.omrglobal.com/industry-reports/polycystic-ovary-syndrome-pcos-market
Key questions
addressed by the report
·
What is
the market growth rate?
·
Which
segment and region dominate the market in the base year?
·
Which
segment and region will project the fastest growth in the market?
·
How
COVID-19 impacted the market?
·
Deviation
from the pre-COVID-19 forecast
·
Most
affected region and segment
·
Who is
the leader in the market?
·
How
players are addressing challenges to sustain growth?
·
Where
is the investment opportunity?
Global PCOS
Market Report Segment
By Drug Type
·
Diuretics
·
Insulin
Sensitizing Agents
·
Antiandrogens
·
Anti-Depressants
·
Ornithine
Decarboxylase Inhibitors
·
Anti-Obesity
·
Oral
Contraceptive Pills
By Diagnosis
Type
·
Ultrasound
·
Pelvic
Exam
·
Blood
Test
·
By
Treatment Type
·
Ovarian
Wedge Resection
·
Laparoscopic
Ovarian Drilling
·
Acupuncture
By
Distribution Channel
·
Hospital
Pharmacies
·
Retail
Pharmacies (Online and Offline)
·
Fertility
Clinics
Global PCOS
Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Abbott
Laboratories
·
Astellas
Pharma Inc.
·
AstraZeneca
plc
·
AVA
Science Inc.
·
Bayer
AG
·
Bristol-Myers
Squibb Co.
·
Dexa
Medica (Dexa Group)
·
Ferring
B.V.
·
GlaxoSmithKline
plc
·
Merck
& Co., Inc.
·
Millendo
Therapeutics, Inc.
·
MyOva
·
Novartis
AG
·
PCOS
Diva LLC
·
Pharmasure
Ltd.
·
Sanofi
SA
·
Sneha
Natura
·
Teva
Pharmaceutical Industries Ltd.
·
The
Himalaya Drug Co.
·
Theralogix,
LLC
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/polycystic-ovary-syndrome-pcos-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment